申请人:RSEM, LIMITED PARTNERSHIP
公开号:US20140024606A1
公开(公告)日:2014-01-23
Novel peptidomimetics comprising N-amino cyclic urea residues are disclosed. Use of such peptidomimetics for modulating the activity of CD36 or IL-1 receptor in a cell, and for treating CD36- or IL-1-related disease, disorder or condition is also described
本发明揭示了含有N-氨基环状脲残基的新型肽类似物。还描述了使用这种肽类似物来调节细胞中CD36或IL-1受体的活性,并用于治疗与CD36或IL-1相关的疾病、障碍或病况。